Mathilde Merlet
general manager
Mathilde Merlet is the general manager for Canada at Eli Lilly & Co., a pharmaceutical company that has seen significant market success with its GLP-1 products, positioning itself strongly against competitors like Novo Nordisk.
Global Media Ratings
Dominance
0.00%
Persistence
0 wks
Reach
34,899
Power
1,561$
Sentiment
9.00
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Canada | 1 | 9.00 | 0.09% | +0% | 38,005,238 | 34,899 | $1,700,000 | 1,561$ |
| Totals | 1 | 38,005,238 | 34,899 | $1,700,000 | 1,561$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Canada:
Mathilde Merlet, Eli Lilly’s general manager for Canada, discussed the unprecedented efficacy of the new class of medication.
9
Evan Seigerman
Per Bank
Khalid Bhatti
Dave Suchon
Farris Smith
Ebele Ola
Kyle Zien
Brett Belchetz
Adam Dudum
The Globe and Mail: Canada will be a launching pad for the global race for generic Ozempic